Literature DB >> 1644921

An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.

T Hayek1, T Chajek-Shaul, A Walsh, L B Agellon, P Moulin, A R Tall, J L Breslow.   

Abstract

We have previously described two transgenic mouse lines, one heterozygous for the human apo A-I gene and the other heterozygous for a human cholesteryl ester transfer protein (CETP) minigene driven by the mouse metallothionein-I gene promoter. In the current study, these two lines were crossed producing control, HuCETPTg, HuAITg, and HuAICETPTg mice to study the influence of CETP on HDL cholesterol levels, particle size distribution, and metabolism in animals with mouse and human-like HDL. In the HuCETPTg and HuAICETPTg animals, zinc induction approximately doubled plasma CETP activity, with no activity in plasma from the control and HuAITg animals. The only significant effect of CETP on lipoprotein subfraction cholesterol concentrations was for HDL-C. Compared to control animals, HuCETPTg animals had lower HDL-C, 20% before and 35% after Zn induction, and compared to HuAITg animals, HuAICETPTg animals had lower HDL-C, 35% before and 66% after Zn induction. Control and HuCETPTg HDL consist primarily of a single size population with a mean diameter of 10.00 +/- 0.10 nm and 9.71 +/- 0.05 nm, respectively. HuAITg HDL consists primarily of three distinct HDL size subpopulations with peak diameters of 10.35 +/- 0.08 nm, 8.80 +/- 0.06 nm, 7.40 +/- 0.10 nm, and HuAICETPTg HDL also consists primarily of three distinct HDL size subpopulations with peak diameters of 9.87 +/- 0.05 nm, 8.60 +/- 0.10 nm, 7.30 +/- 0.15 nm before, and 9.71 +/- 0.08 nm, 8.50 +/- 0.11 nm, 7.27 +/- 0.15 nm after zinc induction, respectively. Western blotting analysis of nondenaturing gradient gels of plasma with a monoclonal antibody to CETP indicated that in HuCETPTg and HuAICETPTg mice, 22 and 100%, respectively, of the CETP was HDL associated. Turnover studies with HDL doubly labeled with 125I apo A-I and 3H cholesteryl linoleate indicated that the CETP-induced fall in HDL-C was associated with increased HDL-cholesterol ester fractional catabolic rate in both the absence and presence of human apo A-I, suggesting CETP-mediated transfer of HDL-cholesterol ester to apo B-containing lipoproteins. In summary, these studies suggest that CETP has a much more profound effect on HDL cholesterol levels in transgenic animals expressing human apo A-I. This may be due to an enhanced interaction of CETP with human compared to mouse apo A-I or to the HDL particles they produce.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644921      PMCID: PMC443127          DOI: 10.1172/JCI115887

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

Review 1.  Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.

Authors:  A R Tall
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

Review 2.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

3.  Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.

Authors:  S Yamashita; D L Sprecher; N Sakai; Y Matsuzawa; S Tarui; D Y Hui
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 4.  High density lipoprotein metabolism.

Authors:  S Eisenberg
Journal:  J Lipid Res       Date:  1984-10       Impact factor: 5.922

5.  Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism.

Authors:  M E Whitlock; T L Swenson; R Ramakrishnan; M T Leonard; Y L Marcel; R W Milne; A R Tall
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Effects of injecting exogenous lipid transfer protein into rats.

Authors:  Y C Ha; L B Chang; P J Barter
Journal:  Biochim Biophys Acta       Date:  1985-02-08

Review 7.  Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis.

Authors:  N E Miller
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

8.  High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.

Authors:  A Walsh; Y Ito; J L Breslow
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

9.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

Authors:  W P Castelli; R J Garrison; P W Wilson; R D Abbott; S Kalousdian; W B Kannel
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

10.  Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro.

Authors:  C Glass; R C Pittman; M Civen; D Steinberg
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

View more
  24 in total

1.  Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure.

Authors:  Guoqing Cao; Thomas P Beyer; Youyan Zhang; Robert J Schmidt; Yan Q Chen; Sandra L Cockerham; Karen M Zimmerman; Sotirios K Karathanasis; Ellen A Cannady; Todd Fields; Nathan B Mantlo
Journal:  J Lipid Res       Date:  2011-09-25       Impact factor: 5.922

2.  Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance.

Authors:  Jonathan M Nizar; Wuxing Dong; Robert B McClellan; Mariana Labarca; Yuehan Zhou; Jared Wong; Donald G Goens; Mingming Zhao; Nona Velarde; Daniel Bernstein; Michael Pellizzon; Lisa M Satlin; Vivek Bhalla
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-03

Review 3.  Molecular regulation of HDL metabolism and function: implications for novel therapies.

Authors:  Daniel J Rader
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

4.  Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.

Authors:  Hongwen Zhou; Zhiqiang Li; David L Silver; Xian-Cheng Jiang
Journal:  Biochim Biophys Acta       Date:  2006-09-20

5.  Structural studies of a baboon (Papio sp.) plasma protein inhibitor of cholesteryl ester transferase.

Authors:  G W Buchko; A Rozek; P Kanda; M A Kennedy; R J Cushley
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

6.  ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.

Authors:  Richard E Morton; Yan Liu; Lahoucine Izem
Journal:  J Lipid Res       Date:  2019-09-11       Impact factor: 5.922

7.  Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.

Authors:  L Masucci-Magoulas; P Moulin; X C Jiang; H Richardson; A Walsh; J L Breslow; A Tall
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters.

Authors:  I Hardardóttir; A H Moser; J Fuller; C Fielding; K Feingold; C Grünfeld
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

Review 9.  Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.

Authors:  Johannes M M Boots; Maarten H L Christiaans; Johannes P van Hooff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistic studies in human Apo A-I transgenic and control mice.

Authors:  T Hayek; Y Ito; N Azrolan; R B Verdery; K Aalto-Setälä; A Walsh; J L Breslow
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.